Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Ren Fail ; 45(1): 2147083, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36748746

ABSTRACT

BACKGROUND: Tacrolimus is a potent immunosuppressant, but has various side effects, with nephrotoxicity being the most common. Renal fibrosis is an important process of tacrolimus nephrotoxicity. Therefore, it is important to identify the factors that contribute to renal fibrosis after tacrolimus nephrotoxicity, and control its development. METHODS: The present study aims to determine whether tacrolimus may speed up the course of renal fibrosis by upregulating noncoding RNA activated by DNA damage (NORAD) to compete with miR-136-5p, and activating the TGF-ß1/Smad3 pathway. Furthermore, in vivo rat models and in vitro cell models were established. Then, the expression levels of NORAD and miR-136-5p were determined by RT-qPCR, while the expression of the TGF-ß1/Smad3 pathway was determined by western blot and RT-qPCR. In order to investigate the interaction between NORAD and miR-136-5p, as well as miR-136-5p and SYK, two luciferase reporters were employed. The renal fibrosis of mice was observed using Masson and PAS staining. The expression of inflammatory factors IL-1, IL-6, MCP-1 and TNF-α was detected by ELISA. RESULTS: In the in vitro experiments, NORAD was upregulated, while miR-136-5p was downregulated after tacrolimus induction. The expression of the TGF-ß1/Smad3 pathway correspondingly changed after the induction by tacrolimus. In the in vivo experiments, the expression of NORAD and miR-136-5p, and the trend for renal fibrosis were consistent with the results in the in vitro experiments. Furthermore, the inflammatory factors correspondingly changed with the severity of renal fibrosis. Moreover, the expression trend of the TGF-ß1/Smad3 pathway in tacrolimus-induced rats was consistent with that in the in vitro experiments. CONCLUSION: Through in vitro and in vivo experiments, the present study was able to successfully prove that tacrolimus upregulates NORAD to compete with miR-136-5p, resulting in a decrease in miR-136-5p expression, which in turn activates the TGF-ß1/smad3 pathway, and finally induces the aggravation of renal fibrosis.


Subject(s)
Kidney Diseases , MicroRNAs , RNA, Long Noncoding , Animals , Mice , Rats , DNA Damage , Fibrosis , Kidney Diseases/chemically induced , Kidney Diseases/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , RNA, Untranslated/pharmacology , Signal Transduction , Tacrolimus/toxicity , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , RNA, Long Noncoding/genetics
2.
Physiol Genomics ; 55(2): 90-100, 2023 02 01.
Article in English | MEDLINE | ID: mdl-36645668

ABSTRACT

Bone marrow mesenchymal stem cells (BMSCs) exert pivotal roles in suppressing immune rejection in organ transplantation. However, the function of BMSCs on immune rejection in renal transplantation remains unclear. This study aimed to evaluate the effect and underlying mechanism of BMSCs on immune rejection in renal transplantation. Following the establishment of the renal allograft mouse model, the isolated primary BMSCs were injected intravenously into the recipient mice. Enzyme-linked immunosorbent assay, flow cytometry, hematoxylin-eosin staining, and Western blot assays were conducted to investigate BMSCs' function in vivo and in vitro. Mechanistically, the underlying mechanism of BMSCs on immune rejection in renal transplantation was investigated in in vivo and in vitro models. Functionally, BMSCs alleviated the immune rejection in renal transplantation mice and facilitated B cell activation and the production of IL-10+ regulatory B cells (Bregs). Furthermore, the results of mechanism studies revealed that BMSCs induced the production of IL-10+ Bregs by facilitating a proliferation-inducing ligand (APRIL) phosphorylation to enhance immunosuppression and repressed renal transplant rejection by promoting APRIL phosphorylation to induce IL-10+ Bregs. BMSCs prevent renal transplant rejection by facilitating APRIL phosphorylation to induce IL-10+ Bregs.


Subject(s)
B-Lymphocytes, Regulatory , Kidney Transplantation , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Mice , Animals , Interleukin-10 , Graft Rejection , Phosphorylation , Mesenchymal Stem Cell Transplantation/methods , Bone Marrow Cells
3.
Aging Cell ; 20(10): e13461, 2021 10.
Article in English | MEDLINE | ID: mdl-34499402

ABSTRACT

Bone marrow-derived mesenchymal stem cell (BMSC)-derived small extracellular vesicles (sEVs) are potent candidates for the suppression of acute rejection post-renal allograft and have been reported to halt dendritic cells (DCs) maturation. However, whether BMSC-derived sEVs mitigate acute rejection post-renal allograft by targeting DCs is still unclear. In this study, donor BMSC-derived sEVs (sEVs) relieved the inflammatory response and suppressed mature DCs (mDCs) location in kidney grafts, and increased regulatory T (Treg) cell population in the spleens of the rats that underwent kidney allograft. In lipopolysaccharide (LPS)-stimulated immature DCs (imDCs), sEVs suppressed the maturation and migration of DCs and inactivated toll-like receptor 4 (TLR4) signaling. Compared with LPS-treated imDCs, imDCs treated with LPS+sEVs promoted CD4+ T cells differentiated toward Treg cells. Subsequently, we found that Loc108349490, a long non-coding RNA (lncRNA) abundant in sEVs, mediated the inhibitory effect of sEVs on DC maturation and migration by promoting TLR4 ubiquitination. In rats that underwent an allograft, Loc108349490 deficiency weakened the therapeutic effect of sEVs on acute rejection. The present study firstly found that sEVs alleviated acute rejection post-renal allograft by transferring lncRNA to DCs and screened out the functional lncRNA loaded in sEVs was Loc108349490.


Subject(s)
Allografts/metabolism , Dendritic Cells/metabolism , Extracellular Vesicles/metabolism , Graft Rejection/physiopathology , Mesenchymal Stem Cells/metabolism , Acute Disease , Animals , Cell Differentiation , Humans , Male , Mice , Rats , Rats, Sprague-Dawley , Rats, Wistar
4.
Aging (Albany NY) ; 11(20): 8911-8924, 2019 10 26.
Article in English | MEDLINE | ID: mdl-31655796

ABSTRACT

OBJECTIVE: To investigate the mechanism of immature dendritic cells-derived exosomes (imDECs) in the regulation of T cell differentiation and immune tolerance in renal allograft model mice. RESULTS: imDECs significantly improved the percent of survival, relieved inflammatory response, and reduced CD4+T cell infiltration. In addition, imDECs reduced the rejection associated cytokines in allograft mice, and increased the percentage of Foxp3+CD4+T cells in spleen and kidney tissues. imDECs suppressed the IL17+CD4+T cells and promoted the Foxp3+CD4+T cells under Th17 polarization condition. Moreover, miR-682 was found to be highly expressed in imDECs which suppressed the IL17+CD4+T cells and promoted the Foxp3+CD4+T cells. Luciferase reporter assay showed ROCK2 was a target of miR-682, and ROCK mRNA level was negative correlated with miR-682 mRNA level. CONCLUSION: miR-682 was highly expressed in imDECs, and imDECs-secreted miR-682 promoted Treg cell differentiation by negatively regulating ROCK2 to promote immune tolerance in renal allograft model mice. METHODS: Renal allograft model mice were established, and imDECs or mature dendritic cells-derived exosomes (mDECs) were injected into model mice. Rejection associated cytokines IFN-γ, IL-2, IL-17 levels in plasma were detected by ELISA. IL-17A, Foxp3, miR-682, ROCK2, p-STAT3, p-STAT5 expressions were measured by qRT-PCR or western blot.


Subject(s)
CD4-Positive T-Lymphocytes/physiology , Cell Differentiation/physiology , Dendritic Cells/physiology , Exosomes/physiology , Kidney Transplantation , Animals , Cytokines/genetics , Cytokines/metabolism , Female , Gene Expression Regulation/immunology , Graft Rejection/immunology , Lymphocyte Activation , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , MicroRNAs , Th17 Cells
5.
Int Immunopharmacol ; 75: 105758, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31377589

ABSTRACT

OBJECTIVE: The present study aimed to investigate the functional role of bortezomib in the development of acute allograft rejection (AR) after renal transplant. METHODS: The mouse model of AR was established by allograft kidney transplant followed by the treatment of bortezomib. The serum cytokines, renal function, and the percentage of T follicular helper (Tfh) cells in CD4+ T cells were measured. The effect of miR-15b and interferon-regulatory factor 4 (IRF4) on Tfh cell proliferation and differentiation was assessed by cell transfection technology and CCK-8 assay. The interaction between miR-15b and IRF4 was assessed by luciferase reporter assay. RESULTS: Bortezomib relieved acute AR after renal transplant by suppressing Tfh cell proliferation and differentiation. Meanwhile, bortezomib treatment markedly increased miR-15b expression in AR renal tissues. The upregulation of miR-15b inhibited Tfh cell proliferation and differentiation by reducing IRF4. In addition, bortezomib ameliorated AR by suppressing Tfh cell proliferation and differentiation through miR-15b/IRF4 axis in vitro and in vivo. CONCLUSION: Our findings indicated the mechanism underlying the bortezomib in treating acute AR after renal transplant, and suggested the critical role of miR-15b in Tfh cell proliferation and differentiation, which provided a therapeutic target in attenuating acute AR.


Subject(s)
Bortezomib/therapeutic use , Graft Rejection/drug therapy , Immunosuppressive Agents/therapeutic use , Interferon Regulatory Factors/immunology , Kidney Transplantation , MicroRNAs/immunology , T-Lymphocytes, Helper-Inducer/drug effects , Allografts , Animals , Bortezomib/pharmacology , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cytokines/blood , Female , Graft Rejection/immunology , Immunosuppressive Agents/pharmacology , Male , Mice, Inbred BALB C , Mice, Inbred C57BL , T-Lymphocytes, Helper-Inducer/immunology
6.
J Clin Pharmacol ; 59(6): 890-899, 2019 06.
Article in English | MEDLINE | ID: mdl-30861159

ABSTRACT

The narrow therapeutic window of tacrolimus necessitates daily monitoring and predictive algorithms based on genetic and nongenetic factors. In this study, we constructed predictive algorithms for tacrolimus stable dose in a retrospective cohort of 1045 Chinese renal transplant recipients. All patients were genotyped for CYP3A4 20230T>C (rs2242480), CYP3A4 T>C (rs4646437), CYP3A5*3 6898A>G (rs776746), ABCB1 129T>C (rs3213619); ABCB1 c.1236C>T (rs01128503), ABCB1 c.2677G>T/A (rs2032582) and ABCB1 c.3435C>T (rs1045642) polymorphisms, and the effects of gene-gene and gene-environment interactions on the predictive accuracy of algorithm were evaluated. In wild-type CYP3A4 rs2242480 (TT) carriers, patients who took calcium channel blockers had lower tacrolimus stable doses than those without the concomitant medications (P < 1 × 10-4 ). In contrast, there was no significant difference in mutant type patients. Similarly, the tacrolimus stable doses in wild-type CYP3A5 rs776746 carriers who had hypertension were higher than those without hypertension (P = 4.10 × 10-3 ). More importantly, dose-predictive algorithms with interaction terms showed higher accuracy and better performance than those without interaction terms. Our finding suggested that wild-type CYP3A4 rs2242480 (TT) carriers should be more cautious to take tacrolimus when they are coadministrated with calcium channel blockers, and CYP3A5 rs776746 (AA) carriers may need higher tacrolimus dosage when they are in combination with hypertension.


Subject(s)
Kidney Transplantation , Tacrolimus/administration & dosage , Tacrolimus/therapeutic use , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Adult , Algorithms , Asian People , Calcium Channel Blockers/therapeutic use , Cohort Studies , Cytochrome P-450 CYP3A/genetics , Drug Combinations , Female , Gene-Environment Interaction , Genetic Variation , Humans , Immunosuppressive Agents/therapeutic use , Kidney/drug effects , Male , Middle Aged , Polymorphism, Single Nucleotide , Retrospective Studies , Transplant Recipients
7.
Mol Med ; 24(1): 49, 2018 09 18.
Article in English | MEDLINE | ID: mdl-30241461

ABSTRACT

BACKGROUND: MicroRNAs (miRNAs) contribute to the progression of chronic kidney disease (CKD) by regulating renal homeostasis. This study explored the effects of miR-181a on CKD through the Toll-like receptor (TLR)/nuclear factor-kappa B (NF-κB) pathway by binding to CRY1. METHODS: Seventy male rats were selected and assigned into specific groups: miR-181a mimic, miR-181a inhibitor, and siRNA against CRY1, with each group undergoing different treatments to investigate many different outcomes. First, 24-h urinary protein was measured. ELISA was used to determine the serum levels of SOD, ROS, MDA, IL-1ß, IL-6, and TNF-α. Biochemical tests for renal function were performed to measure albumin, uric acid, and urea in urine and urea nitrogen and creatinine in serum. The glomerulosclerosis index (GSI) and renal tubular epithelial (RTE) cell apoptosis were detected using PASM staining and TUNEL staining, respectively. Finally, RT-qPCR and western blot were done to determine miR-181a, CRY1, TLR2, TLR4, and NF-κB expression. RESULTS: CRY1 is the target gene of miR-181a, according to a target prediction program and luciferase assay. Rats diagnosed with CKD presented increases in 24-h urinary protein; GSI; RTE cell apoptosis rate; serum ROS, MDA, IL-1ß, IL-6, and TNF-α; and CRY1, TLR2, TLR4, and NF-κB expression, as well as decreases in SOD level and miR-181a expression. Following transfection with either the miR-181a mimic or si-CRY1, 24-h urinary protein, renal damage, GSI, and cell apoptosis rate were all decreased. In addition, the overexpression of miR-181a or inhibition of CRY1 alleviated the degree of kidney injury through suppression of the TLR/NF-κB pathway. CONCLUSION: miR-181a alleviates both GS and RTE injury in CKD via the down-regulation of the CRY1 gene and the TLR/NF-κB pathway.


Subject(s)
Cryptochromes , MicroRNAs , Renal Insufficiency, Chronic , Toll-Like Receptor 2 , Toll-Like Receptor 4 , Animals , Cryptochromes/genetics , Cryptochromes/metabolism , Down-Regulation , Epithelial Cells/pathology , Kidney Glomerulus/pathology , Kidney Tubules/injuries , Male , NF-kappa B/genetics , NF-kappa B/metabolism , Rats, Sprague-Dawley , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/metabolism , Renal Insufficiency, Chronic/pathology , Sclerosis , Signal Transduction , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism
9.
Sci Rep ; 7: 42192, 2017 02 08.
Article in English | MEDLINE | ID: mdl-28176850

ABSTRACT

Tacrolimus has a narrow therapeutic window and considerable variability in clinical use. Our goal was to compare the performance of multiple linear regression (MLR) and eight machine learning techniques in pharmacogenetic algorithm-based prediction of tacrolimus stable dose (TSD) in a large Chinese cohort. A total of 1,045 renal transplant patients were recruited, 80% of which were randomly selected as the "derivation cohort" to develop dose-prediction algorithm, while the remaining 20% constituted the "validation cohort" to test the final selected algorithm. MLR, artificial neural network (ANN), regression tree (RT), multivariate adaptive regression splines (MARS), boosted regression tree (BRT), support vector regression (SVR), random forest regression (RFR), lasso regression (LAR) and Bayesian additive regression trees (BART) were applied and their performances were compared in this work. Among all the machine learning models, RT performed best in both derivation [0.71 (0.67-0.76)] and validation cohorts [0.73 (0.63-0.82)]. In addition, the ideal rate of RT was 4% higher than that of MLR. To our knowledge, this is the first study to use machine learning models to predict TSD, which will further facilitate personalized medicine in tacrolimus administration in the future.


Subject(s)
Drug Dosage Calculations , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Machine Learning , Renal Insufficiency, Chronic/immunology , Tacrolimus/therapeutic use , Adult , Bayes Theorem , Cohort Studies , Female , Humans , Linear Models , Male , Middle Aged , Multivariate Analysis , Precision Medicine , Renal Insufficiency, Chronic/pathology , Renal Insufficiency, Chronic/surgery , Transplant Recipients
10.
Cell Biochem Biophys ; 70(3): 1713-7, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24973957

ABSTRACT

To report clinical outcomes of kidney transplantation from pediatric brain and cardiac death donors (DBCD) in a single Chinese center and to investigate its feasibility to expand organ donor pool. 18 recipients, transplanted between August 2011 and October 2013 in the First Affiliated Hospital of Zhengzhou University, receive a single graft from DBCD donors age ranged from 1.5 to 13 years old. Renal function expressed as serum creatinine, blood urea nitrogen as well as eGFR values at 1, 2 weeks as well as 1-, 3-, 6-, and 12-months post-transplantation was evaluated. Graft size was also monitored at the same time by ultrasonography. In addition, delayed graft function, acute rejection, surgical complication as well as patient and graft survival were also assessed. The primary causes of DBCD donors included six cases of severe brain trauma and three cases of cerebral hemorrhage. The mean age of DBCD donors was (7.2 ± 3.4) years (range 1.5-13). The mean weight of DBCD donors was (29.8 ± 15.3) kilogram (range 13-67). The mean height of DBCD donors was (118.3 ± 27.8) centimeter (range 70-173). ECMO was applied to DBCD donors to avoid warm ischemia time and the applicating time was (79.8 ± 44.5) (range 32-180) minutes.There were seven males and 11 females recipients. Among which, 16 recipients were pediatrics and two recipients were adults. The mean age of the recipients was (14.6 ± 9.7) years (range 4-47). The mean weight of recipients was (31.9 ± 12.4) kilogram (range 11-54). The mean height of recipients was (138.0 ± 23.7) centimeter (range 84-172). Renal function recovered to normal within the first-week post-operation except one recipient which occurred acute rejection. Two cases of renal artery stenosis were found 2-week and 3-month post-transplantation, respectively. They subsequently underwent ballon angioplasty and followed up for 8 and 12 months, respectively, and no recurrence was found. One recipient developed ureteral leak. Five weeks later, the ureter leak healed after adequate drainage and prolongation of indwelling catheter. Graft size significantly and continuously increased during the first year, especially in the first 3-month post-transplantation. All the 18 recipients are alive at the last follow-up. Among which, 16 recipients are followed up for 12 months and 1-year recipient/graft survival rate is 100 %. The use of single kidney graft from pediatric DBCD could yield good short-term results.


Subject(s)
Kidney Failure, Chronic/surgery , Kidney Transplantation , Adolescent , Adult , Blood Urea Nitrogen , Child, Preschool , Constriction, Pathologic/etiology , Creatine/blood , Female , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection/prevention & control , Humans , Immunosuppressive Agents/therapeutic use , Kidney/diagnostic imaging , Male , Middle Aged , Organ Size , Pneumonia/etiology , Tissue Donors , Ultrasonography , Young Adult
11.
Di Yi Jun Yi Da Xue Xue Bao ; 24(9): 1058-60, 2004 Sep.
Article in Chinese | MEDLINE | ID: mdl-15447864

ABSTRACT

OBJECTIVE: To investigate the clinical effect of continuous suture technique for closure of surgically created arteriovenous fistulas at different sites. METHOD: A total of 160 patients with chronic renal failure underwent surgery to create arteriovenous fistulas at different sites, which were closed with continuous suture technique. RESULTS: The time for vessel anastomosis was reduced with this suture technique, and the success rate of anastomosis at one time and the overall operative success rate were improved, with also reduction of complications to achieve satisfactory clinical results. CONCLUSION: Continuous suture technique well suits the demand in anastomosis of arteriovenous fistula at different sites, especially in cases with poor vascular condition.


Subject(s)
Arteriovenous Shunt, Surgical , Kidney Failure, Chronic/therapy , Suture Techniques , Adolescent , Adult , Aged , Anastomosis, Surgical , Arteriovenous Shunt, Surgical/methods , Female , Humans , Kidney Failure, Chronic/surgery , Male , Middle Aged , Renal Dialysis
12.
Di Yi Jun Yi Da Xue Xue Bao ; 24(5): 497-500, 2004 May.
Article in Chinese | MEDLINE | ID: mdl-15151816

ABSTRACT

OBJECTIVE: To investigate the transfection efficiency of nuclear factor (NF)-kappaB decoy oligodeoxynucleotides (ODN) mediated by in vivo liposome in human umbilical vascular endothelial cell line ECV-304 under hypothermic and anoxic conditions. METHODS: ECV-304 cells were cultured in RPMI 1640 culture medium containing 10% fetal bovine serum at 37 degrees Celsius; in the presence of 5% CO2. Liposome-ODN complexes were prepared just before use and added to the cells with a liposome-ODN charge ratio of 2:1. ECV-304 cell monolayers were transfected with liposome-ODN complexes containing 0.50, 0.75, 1.00 and 1.25 micromol/L ODN respectively in Euro-Collins solution (ECs) at 4 degrees celsius; and then stored for 2, 4, 6 and 8 hours respectively under anoxic condition. The ODN without liposome was transfected into ECV-304 cells under identical conditions as the control. The distribution of fluorescein isothiocyanate (FITC)-labeled ODN in ECV-304 cells was observed by fluorescence microscope, and the transfection efficiency and mean fluorescence intensity (MFI) were evaluated by flow cytometry. RESULTS: MFI was enhanced as the storage time extended and ODN concentration increased, reaching the peak level at 6 h (P<0.05). After a 6-hour storage, most of the ODN was found to locate in the cell nuclei, and the transfection efficiency did not vary significantly between the groups. Compared with the control group, however, the differences in transfection efficiency and MFI were significant. CONCLUSION: ODN can be highly efficiently transfected into ECV-304 cells by in vivo liposome in ECs under hypothermic and anoxic conditions, which provides an experimental basis for further study of the donor organ preservation at the level of genetic regulation.


Subject(s)
Endothelial Cells/metabolism , Oligonucleotides/pharmacology , Transfection/methods , Cell Hypoxia , Cell Line , Cold Temperature , Humans , Liposomes , Oligonucleotides/administration & dosage , Umbilical Veins/metabolism
13.
Di Yi Jun Yi Da Xue Xue Bao ; 23(9): 925-8, 2003 Sep.
Article in Chinese | MEDLINE | ID: mdl-13129722

ABSTRACT

OBJECTIVE: To investigate the effect of hypoxia-reoxygenation on of endothelium-dependent NO and endothelium-derived hyperpolarizing factor (EDHF) relaxation of. METHODS: The organ chamber technique was employed to study rabbit renal artery rings. By inhibiting the PGI2 relaxation pathway with hypoxia-reoxygenation of the renal artery rings, followed by inhibition of NO and EDHF relaxation pathways respectively, the effects of hypoxia-reoxygenation on NO and EDHF relaxation were observed. RESULTS: Hypoxia-reoxygenation decreased the endothelial NO relaxation of rabbit renal rings, but the endothelial EDHF relaxation. CONCLUSION: Hypoxia-reoxygenation may injure endothelium-derived NO relaxation, but not the endothelium-derived EDHF relaxation of rabbit renal rings.


Subject(s)
Cell Hypoxia/physiology , Endothelium, Vascular/physiology , Oxygen/pharmacology , Renal Artery/physiology , Vasodilation , Acetylcholine/pharmacology , Animals , Biological Factors/physiology , Dose-Response Relationship, Drug , Female , Male , Nitric Oxide/physiology , Rabbits , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...